Needle Free Injection Market PowerPoint PPT Presentations

"The global needle free injection systems market was valued at around USD 9,166 million in 2017 and expected to grow at a CAGR of 16.0% in the forecast period. "

The global needle free injection systems market was valued at around USD 9,166 million in 2017 and expected to grow at a CAGR of 16.0% in the forecast period.

Geographically, the needle free injection system market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).

The Global Needle-free Injection Systems Market size is expected to reach $24.9 billion by 2023, rising at a market growth of 17.4% CAGR during the forecast period. Full Report: http://kbvresearch.com/needle-free-injection-systems-market/

This Report provided by GrandResearchStore is about , sales (consumption) of Needle-Free Injection Device in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Zogenix Inovio Glide Pharma Akra Dermojet

Global Needle Free Injection Market Research Report information: Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals) – Forecast Till 2023

Powder-based, Needle-free Injection System market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Powder-based, Needle-free Injection System market will be able to gain the upper hand as they use the report as a powerful resource.

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

This report studies Needle Free Injection Systems in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 billion by 2021 from USD 9.81 billion in 2016, at a CAGR of 15.5% during the forecast period. The report segments the needle-free injection system market based on product, technology, usability, type, site of delivery, applications, end user and regions.

For more information kindly visit : https://www.bharatbook.com/medical-devices-market-research-reports-759240/needle-free-injections.html Bharat Book Bureau provides the report, on “ Needle Free Injections - Medical Devices Pipeline Assessment, 2016 ”. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development.

According to the latest research report by IMARC Group, The global needle-free drug delivery technology market size reached US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.56% during 2024-2032. More Info:- https://www.imarcgroup.com/needle-free-drug-delivery-technology-market

According to the latest research report by IMARC Group, The global needle-free drug delivery technology market size reached US$ 4.18 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.72 Billion by 2028, exhibiting a growth rate (CAGR) of 5.22% during 2023-2028. More Info:- https://www.imarcgroup.com/needle-free-drug-delivery-technology-market

Industry Report “Needle-Free Drug Delivery Devices Market Research Report – Forecast to 2023” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement

The global Needle-Free Drug Delivery Devices Market is highly fragmented due to the presence of a various large number of players which forms a competitive environment. The report entails all-inclusive information associated with the latest market updates such as new ideas, market size, opportunity, growth path and trends for the forecast period of 2019-2025 to gain competitive edge across the globe. This report also highlights various important strategic mergers and acquisitions, company overview, financial details, and the latest development undertaken.

Some of the top companies operating in the GCC syringes and needles market are – Becton, Dickinson & Company, Nipro Corporation, Baxter International Inc., B. Braun, Terumo Corporation, Medtronic PLC., Smiths Group Inc., Abu Dhabi Medical Devices Company, SAAPP (FZC) LLC., and IBN Sina Medical Factory.

2015-2019 Global Needle-free Drug Delivery Technologies Market Size, Share, Growth & Analysis

Adroit Market Research has announced the addition of the Global Needle Free Drug Delivery Devices Market by company, by country, and by application/type for the competitive landscape analysis.

A Huber needle is defined as a hollow long needle with a tip which can go through silicone septum as well as through skin during chemotherapy. Huber needles are used in lap-band adjustments, dialysis, blood transfusions, and intravenous cancer treatments. Huber needles are of different lengths and are used according to application. It is very important that the Huber needles used by doctors are of proper size, it might induce pain due to wrong size of the needle. Huber needle is used in the intravenous chemotherapy for giving drugs and blood supply in order to prevent infections. The needle guards and plastic wings on the Huber needle prevent causes of injury. These needles are easily disposable and due to this these are considered as friendly services and of excellent product quality.

The global pen needles market size was valued at $1.7 billion in 2022, and is projected to reach $4.5 billion by 2032, growing at a CAGR of 10.3% from 2023 to 2032.

The Global Special Purpose Needles Market was valued at US$ 10.44 billion in 2021 and is predictable to reach US$ 22.01 billion by 2030 which is projected to attain a CAGR of 8.6 % during the forecast period from 2021- 2030. Needles are referred as a device made up of metal, glass, or rubber tubes used for delivering drugs and collecting fluids from the body.

The global hypodermic needles market is growing at a CAGR of 4.60%, and is expected to reach $xx billion during the forecast period 2023-2032. Get a Free Sample.

Safe Needle-free Injection Technology for Markets Worldwide. A U.S. Russian Success Story ... Royalty on adjusted gross sales. Felton International Inc. 11 ...

Market Size – USD 3.10 Billion in 2022, Market Growth – at a CAGR of 11.7%, Market Trends – Rising preference for biosimilar drugs

The growth of the global market is largely driven by the high demand for vaccines and increasing compliance of safety needles. High prevalence of needle stick injuries during drug administration is a key concern for healthcare providers across the globe. Improper disposal of syringe and needles is creating the demand for advanced safety mechanisms in hypodermic needles. Globally, approximately 16 billion injections are administered every year as per the World Health Organization (WHO); however, all the syringes and needles are not properly disposed of. Therefore, several benefits of safety needles such as ease of use during injection and safe delivery of drug or medication are increasing their popularity among healthcare providers.

The growth of the global market is largely driven by the high demand for vaccines and increasing compliance of safety needles. High prevalence of needle stick injuries during drug administration is a key concern for healthcare providers across the globe. Improper disposal of syringe and needles is creating the demand for advanced safety mechanisms in hypodermic needles. Globally, approximately 16 billion injections are administered every year as per the World Health Organization (WHO); however, all the syringes and needles are not properly disposed of. Therefore, several benefits of safety needles such as ease of use during injection and safe delivery of drug or medication are increasing their popularity among healthcare providers.

The medical injection-molded plastics industry has garnered $23,014.7 million revenue in 2021, and it is projected to rise at a rate of 5.7% from 2021 to 2030, to generate $37,899.5 million in 2030. It is ascribed to the rising consumption of plastic in various healthcare applications, including medical devices, mobility aids, and implant packaging. Moreover, the surging research & development expenditure, and technological advancements in the healthcare sector propels the requirement for medical-grade injection-molded polymers.

Big Market Research throws light on "Global and Chinese Insulin Pen Needle Industry, 2015 Market Research Report" Read Complete Report On: http://www.bigmarketresearch.com/global-and-chinese-insulin-pen-needle-industry-2015-research-report-market The Global and Chinese Insulin Pen Needle Industry, 2010-2020 Market Research Report is a professional and in-depth study on the current state of the global Insulin Pen Needle industry with a focus on the Chinese market. The report provides key statistics on the market status of the Insulin Pen Needle manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Needle-free Delivery technology Market is beneficial over conventional delivery technologies reducing patients concern regarding the use of needles. Additional benefits include fast delivery and no issues related to needle disposal.

Global Syringe and Needle Market: Needle Research Report -Forecast to 2027 analysis by End users (Clinic, Hospital, Ambulances, Medical institution) by region (Europe, US) - Forecast to 2027

The rising prevalence of chronic diseases such as diabetes coupled with rise in the diabetic population globally are the key factors driving the pen needles market.

The rising prevalence of chronic diseases such as diabetes coupled with rise in the diabetic population globally are the key factors driving the pen needles market.

Global Self-Injections Market is expected to reach USD 119.5 billion by 2024, from USD 23.4 billion in 2016 growing at the CAGR of 22.6 % in the forecast period 2017 to 2024.

Global Self-Injections Market is expected to rise from its initial estimated value of USD 34.94 billion in 2018 to an estimated value of USD 173.75 billion by 2026, registering a CAGR of 22.2% in the forecast period of 2019-2026. This rise in market value can be attributed to rising demand of self-injection devices.

The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations.

Global Injectable Drug Delivery Market is expected to reach USD 1,104,096.5 million by 2025 from USD 378,998.2 million in 2017, at a CAGR of 12.4% in the forecast period 2018 to 2025.

Global Injectable Drug Delivery Market is expected to reach USD 1,104,096.5 million by 2025 from USD 378,998.2 million in 2017, at a CAGR of 12.4% in the forecast period 2018 to 2025.

The global needle-free injectors market size was estimated to be US$ 5.7 billion in 2020 and is expected to reach US$ 27.5 billion by 2031 at a CAGR of 15.5%. Some of the major factors driving this market's growth are the rising prevalence of chronic disease, rising incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, and rising demand for self-injection devices. However, the high development cost of needle-free injection systems compared to traditional needle injection may stifle market growth throughout the forecast period.

The study segments Pen Needles industry in light of major classification such as product type, potential markets, application, and end-user.

The South Korea Drug Delivery Devices Market report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices... To know more, Click on the link below https://www.kenresearch.com/healthcare/medical-devices/south-korea-drug-delivery-devices/135990-91.html

Spain Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices”, large hospitals across the country acquire or merge with medium and small hospitals to enhancing the quality of treatment... For more information on the market research report please refer to the below link: https://www.kenresearch.com/healthcare/medical-devices/spain-drug-delivery-devices/135988-91.html

The various Drug Delivery Devices in North America are Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

[368 Pages Report] Injectable drug delivery Market report categorizes the global market by Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors], Formulations [Liposomes, Microspheres, & Nanoparticles], Therapeutics [Diabetes & Oncology] Market & Geography - Forecasting - 2017"

Injectable drug delivery Market report categorizes the global market by Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors], Formulations [Liposomes, Microspheres, & Nanoparticles] & Geography.

[368 Pages Report] Injectable drug delivery Market report categorizes the global market by Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors], Formulations [Liposomes, Microspheres, & Nanoparticles], Therapeutics [Diabetes & Oncology] Market & Geography - Forecasting – 2017

The injectable drug delivery devices market consists of sales of injectable drug delivery devices and related products such as conventional syringes, needle-free injectors, auto injectors and pen injectors by entities (organizations, sole traders, and partnerships). The market includes the sales of the injectable devices that have been extensively utilized for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and others to treat medical conditions ranging from cancer, diabetes to autoimmune disorders.

Micro syringes are devices used for medical purposes such as fluid injection and for extracting fluid from the body. These syringes have a hollow and cylindrical structure. There are two types of syringes – autosamplers and manual. Autosamplers are used on a large scale, owing to their superiority over manual injection systems as well as the role it plays in chromatography for approval of the drugs. Based on the types of needles, there are two types of syringes – fixed and removable. Removable needles help to utilize different sizes of needles on the same syringe barrel. They can be replaced when there is a bending observed. It can be further differentiated based on custom lengths and different point styles. However, fixed needles are economical, very easy to handle & use, and are not autoclavable.

Human Insulin market

Syringes Market size is estimated to reach $35,901 million by 2026, growing at a CAGR of 7.81% over 2021-2026. Syringe is a medical device with a hypodermic needle that is used to inject fluid into, or withdraw fluid from, the body. A medical syringe consists of a needle attached to a hollow cylinder that is fitted with a sliding plunger which contains lubricant that is injected subcutaneously through intravenous therapy.

Syringes Market size is estimated to reach $35,901 million by 2026, growing at a CAGR of 7.81% over 2021-2026. Syringe is a medical device with a hypodermic needle that is used to inject fluid into, or withdraw fluid from, the body. A medical syringe consists of a needle attached to a hollow cylinder that is fitted with a sliding plunger which contains lubricant that is injected subcutaneously through intravenous therapy.

Drug delivery generally refers to formulations, approaches, technologies and systems for transporting a pharmaceutical compound in the body. The injectable drug delivery devices consist of needle-free injectors, conventional syringes, auto injectors and pen injectors.

Global Injectable Drug Delivery Market, By Type (Devices {Conventional Injection, Self-Injection}, Formulations {Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations}, Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User (Hospitals & Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Industry Trends and Forecast to 2024

The global syringes market size was valued at $15,340 Million in 2019, and is projected to reach $32,394.74 Million by 2027, registering a CAGR of 9.6 % from 2020 to 2027.

Global Insulin Pump Market will be US$ 16 Billion by 2025. Insulin pumps are very convenient for people who need multiple daily insulin injections.

Read here the latest updates on the Epinephrine Market Analysis published by CMI team

The global disposable syringes market accounted for $5,450 million in 2018, and is expected to reach $8,113.7 million by 2026, registering a CAGR of 5.1% from 2019 to 2026.